Vasculitis UK is pleased to announce its 2022 call for research proposals. The call launches on 31st August with a deadline for applications of 7th October 2022. Decisions will be …
WORD Day Webinar
WORD: World yOung Rheumatic Diseases Day, Friday 18 March In line with their initiative to spread the word about early diagnosis and referrals to paediatric rheumatology experts, the WORD committee …
Campaigning for free Covid tests
Join us in calling on the UK Government to continue free tests for people who are eligible for COVID-19 treatments, their families and close contacts. The UK Government is ending …
Rituximab and Covid-19
The MedicineMatters website (a resource for healthcare professionals) is offering a 13-minute video of a discussion between Prof David Jayne of Cambridge University and Prof Sebastian E. Sattui of theUniversity …
IgA vasculitis – paediatric practitioners sought …
… to help develop guidelines for the management of IgA vasculitis (HSP) in children The EATC4C are in the process of developing UK guidelines on the management of children with …
Melody Study (updated)
UPDATE 6 Feb 2022: We have good news – the invitations to the MELODY study (Mass evaluation of lateral flow immunoassays (at home finger prick antibody tests) for the detection of …
Survey – impact of steroids
Are you being treated with steroids for your rheumatic condition? We need your help to test a new questionnaire about steroid impact on quality of life for people living in …
UKIVAS Vasculitis Webinar
The Second UKIVAS Online Educational Vasculitis Webinar for Medical Professionals Over two days, November 17th and 18th 2021, UKIVAS, the UK & Ireland Vasculitis Study Group, teamed up in partnership with the Royal …
New Research Study
Would you like to help with a research study to better understand why some people with inflammatory conditions affecting the joints or the gut, and treated with immune suppressing medications …
Volunteers needed for trial
Volunteers are needed for The PROTECT V Trial – Led by Addenbrookes Hospital This new exciting trial, led by Dr Rona Smith at Addenbrookes, looks at how patients who are at particularly high risk …